Literature DB >> 7714205

Rapid detection and characterization of foot-and-mouth disease virus by restriction enzyme and nucleotide sequence analysis of PCR products.

F Locher1, V V Suryanarayana, J D Tratschin.   

Abstract

Reverse transcription coupled with PCR was used for the detection of foot-and-mouth disease virus serotypes A, C, and O in organ extracts from experimentally infected cattle. Primers were selected from conserved sequences flanking the genome region coding for the major antigenic site of the capsid located in the C-terminal part of viral protein 1 (VP1). Because this region of the capsid is highly variable its coding sequence is considered to be the most appropriate for the characterization of virus isolates and, therefore, for the determination of the epidemiological relationships between viruses of the same serotype. For differentiation between serotypes and for detailed characterization of individual virus isolates restriction enzyme cleavage and nucleotide sequence analysis of the respective PCR products were carried out. In order to minimize the time required for sample preparation from clinical material, viral RNA was released from particles by heating the sample for 5 min at 90 degrees C. Finally, an air thermocycler was used, which allows performance of a PCR of 30 cycles in approximately 20 min. The results show that reverse transcription PCR followed by restriction enzyme analysis and/or nucleotide sequence analysis of the PCR products is useful for the rapid detection and differentiation of foot-and-mouth disease virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714205      PMCID: PMC227963          DOI: 10.1128/jcm.33.2.440-444.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  [Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22].

Authors:  A M Onishchenko; N A Petrov; V M Blinov; S K Vasilenko; L S Sandakhchiev
Journal:  Bioorg Khim       Date:  1986-03

2.  The 1993 Italian foot-and-mouth disease epidemic: epidemiological features of the four outbreaks identified in Verona province (Veneto region).

Authors:  S Maragon; E Facchin; F Moutou; I Massirio; G Vincenzi; G Davies
Journal:  Vet Rec       Date:  1994-07-16       Impact factor: 2.695

3.  Molecular cloning of cDNA from foot-and-mouth disease virus C1-Santa Pau (C-S8). Sequence of protein-VP1-coding segment.

Authors:  N Villanueva; M Dávila; J Ortín; E Domingo
Journal:  Gene       Date:  1983-08       Impact factor: 3.688

4.  Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12.

Authors:  B H Robertson; M J Grubman; G N Weddell; D M Moore; J D Welsh; T Fischer; D J Dowbenko; D G Yansura; B Small; D G Kleid
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

5.  Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus.

Authors:  A J Makoff; C A Paynter; D J Rowlands; J C Boothroyd
Journal:  Nucleic Acids Res       Date:  1982-12-20       Impact factor: 16.971

6.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.

Authors:  B H Robertson; D M Moore; M J Grubman; D G Kleid
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

9.  VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences.

Authors:  M E Piccone; G Kaplan; L Giavedoni; E Domingo; E L Palma
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

10.  The molecular basis of the antigenic variation of foot-and-mouth disease virus.

Authors:  E Beck; G Feil; K Strohmaier
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  7 in total

1.  Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization.

Authors:  G E Buck
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 2.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Development of reverse transcription-PCR (oligonucleotide probing) enzyme-linked immunosorbent assays for diagnosis and preliminary typing of foot-and-mouth disease: a new system using simple and aqueous-phase hybridization.

Authors:  S Alexandersen; M A Forsyth; S M Reid; G J Belsham
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Detection of foot and mouth disease virus by RT-PCR and microplate hydridization assay using inactivated viral antigens.

Authors:  D Barlic-Maganja; J Grom; I Toplak; P Hostnik
Journal:  Vet Res Commun       Date:  2004-02       Impact factor: 2.459

5.  Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses.

Authors:  W Vangrysperre; K De Clercq
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey.

Authors:  Joern Klein; Unal Parlak; Fuat Ozyörük; Laurids S Christensen
Journal:  BMC Vet Res       Date:  2006-12-04       Impact factor: 2.741

7.  Foot-and-mouth disease virus carrier status in Bos grunniens yaks.

Authors:  Huiyun Chang; Yanbin Ma; Tong Lin; Guozheng Cong; Junzheng Du; Jinling Ma
Journal:  Virol J       Date:  2013-03-11       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.